Targeted therapy in the management of metastatic BRAF V600–mutant melanoma: A case study

Professor Roger Ngan, a specialist in clinical oncology, provides insights into the treatment landscape of melanoma and his considerations when managing a patient with metastatic BRAF V600–mutant melanoma.